Be sure to assess women 67–85 years of age who suffered a fracture and recommend a bone mineral density (BMD) test or a prescription for a drug to treat osteoporosis in the six months after the fracture. This is key quality measure is part of the Healthcare Effectiveness Data and Information Set (HEDIS).
Do you know about exclusions?
- Patients who had a BMD test during the 730 days (24 months) prior to the episode.
- Patients who had a claim/encounter for osteoporosis therapy during the 365 days (12 months) prior to the episode.
- Patients who received a dispensed prescription or had an active prescription to treat osteoporosis during the 12 months prior to the episode.
Helpful tips to close gaps in care:
- Ask all female patients 67-85 years of age if they’ve had a fracture since their last visit.
- Consider writing a prescription for a BMD test at time of fracture.
- If patients are unable or unwilling to have a BMD test, prescribe osteoporosis medications if appropriate.
- Place a reminder in the patient’s chart for a BMD test.
- Partner with your EmblemHealth team to offer in home BMD screening assessments.
- Use telehealth visits to review, document, and prescribe medication, when appropriate.
- Educate patients on safety and fall prevention.
JP 62160 05/2023
